New Diabetes Campaign Raises Controversy

ByALI MOHAMADI
November 17, 2004, 11:48 AM

Nov. 18, 2004 — -- A national public service campaign aims to convince individuals with Type II diabetes that getting a simple blood test will help them stay healthy, but some doctors fear this strategy may lull diabetics into ignoring other serious health concerns.

A coalition of 50 U.S. mayors and health advocates brought its message to Washington today to launch the effort, called "Aim. Believe. Achieve: The Diabetes A1C Initiative." The goal is to raise awareness of a test for hemoglobin A1C, a molecule formed when sugars bind to hemoglobin circulating in the blood.

The test is usually performed every three or four months, usually in a doctor's office. The physician needs just a drop of blood to read the patient's A1C value.

Most diabetics are already experienced at checking their blood-sugar levels frequently during the day using a home device. But these blood-sugar tests show a patient's level at a single point in time, and levels may fluctuate wildly with diet and after a patient takes medications. An A1C test reflects a person's average sugar levels over a two- to three-month period, giving a more stable picture of blood-sugar control.

Proponents of the initiative argue this is the best way to discover how effective treatment has been. They say diabetics should have their A1C checked frequently, aiming for a value of less than 7 percent.

But some in the medical community believe the campaign -- largely funded by Aventis, maker of the Type II diabetes medication Amaryl -- will mislead patients into believing that keeping their blood-sugar level within normal limits is a cure-all for the disease.

"Imagine you are a doctor sitting in front of a patient with Type II diabetes holding up your hand with all five fingers extended," said Dr. David Slawson, a professor of family medicine at the University of Virginia.

"The thumb is smoking, the index finger is blood pressure, the third and fourth fingers are lipids, aspirin, and a particular diabetic medication, metformin, and the pinky is blood sugar," he said. "The first four fingers dwarf the pinky, which is the least important, if at all."

Sponsored Content by Taboola